Brevan Howard Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,482	Closed	-$27K	–	975
2024 Q1	$27K	Sell	10,482 -7,277	-41%	-$18.8K	﹤0.01%	906
2023 Q4	$44.4K	Buy	+17,759	New	+$44.4K	﹤0.01%	950